NU SKIN ENTERPRISES INC - A (NUS) Fundamental Analysis & Valuation
NYSE:NUS • US67018T1051
7.17 USD
+0.06 (+0.84%)
At close: Mar 13, 2026
7.17 USD
0 (0%)
After Hours: 3/13/2026, 8:04:00 PM
This NUS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
NUS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making NUS a very profitable company, without any liquidiy or solvency issues. NUS is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, NUS could be worth investigating further for value investing!.
1. NUS Profitability Analysis
1.1 Basic Checks
- In the past year NUS was profitable.
- NUS had a positive operating cash flow in the past year.
- Of the past 5 years NUS 4 years were profitable.
- Each year in the past 5 years NUS had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of NUS (11.40%) is better than 83.78% of its industry peers.
- NUS has a Return On Equity of 19.90%. This is amongst the best in the industry. NUS outperforms 89.19% of its industry peers.
- NUS's Return On Invested Capital of 6.50% is fine compared to the rest of the industry. NUS outperforms 62.16% of its industry peers.
- NUS had an Average Return On Invested Capital over the past 3 years of 4.60%. This is significantly below the industry average of 11.32%.
- The 3 year average ROIC (4.60%) for NUS is below the current ROIC(6.50%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.4% | ||
| ROE | 19.9% | ||
| ROIC | 6.5% |
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
1.3 Margins
- The Profit Margin of NUS (10.79%) is better than 86.49% of its industry peers.
- NUS's Profit Margin has improved in the last couple of years.
- The Operating Margin of NUS (6.12%) is better than 62.16% of its industry peers.
- In the last couple of years the Operating Margin of NUS has declined.
- The Gross Margin of NUS (69.45%) is comparable to the rest of the industry.
- NUS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.12% | ||
| PM (TTM) | 10.79% | ||
| GM | 69.45% |
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
2. NUS Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
- NUS has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for NUS has been reduced compared to 5 years ago.
- NUS has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.71 indicates that NUS is not in any danger for bankruptcy at the moment.
- NUS has a Altman-Z score of 3.71. This is amongst the best in the industry. NUS outperforms 81.08% of its industry peers.
- NUS has a debt to FCF ratio of 4.87. This is a neutral value as NUS would need 4.87 years to pay back of all of its debts.
- NUS has a better Debt to FCF ratio (4.87) than 70.27% of its industry peers.
- NUS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
- NUS has a Debt to Equity ratio of 0.25. This is comparable to the rest of the industry: NUS outperforms 59.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 4.87 | ||
| Altman-Z | 3.71 |
ROIC/WACC0.91
WACC7.15%
2.3 Liquidity
- NUS has a Current Ratio of 2.08. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.08, NUS is in line with its industry, outperforming 45.95% of the companies in the same industry.
- NUS has a Quick Ratio of 1.40. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
- NUS's Quick ratio of 1.40 is in line compared to the rest of the industry. NUS outperforms 51.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.4 |
3. NUS Growth Analysis
3.1 Past
- NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.76%, which is quite impressive.
- The earnings per share for NUS have been decreasing by -18.78% on average. This is quite bad
- NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.26%.
- Measured over the past years, NUS shows a very negative growth in Revenue. The Revenue has been decreasing by -10.47% on average per year.
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%
3.2 Future
- The Earnings Per Share is expected to grow by 1.27% on average over the next years.
- The Revenue is expected to grow by 1.05% on average over the next years.
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. NUS Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 5.56, which indicates a rather cheap valuation of NUS.
- NUS's Price/Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 97.30% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.70, NUS is valued rather cheaply.
- The Price/Forward Earnings ratio is 7.10, which indicates a rather cheap valuation of NUS.
- 91.89% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of NUS to the average of the S&P500 Index (23.84), we can say NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.56 | ||
| Fwd PE | 7.1 |
4.2 Price Multiples
- NUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NUS is cheaper than 100.00% of the companies in the same industry.
- 89.19% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.5 | ||
| EV/EBITDA | 2.27 |
4.3 Compensation for Growth
- NUS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.27%
EPS Next 3YN/A
5. NUS Dividend Analysis
5.1 Amount
- NUS has a Yearly Dividend Yield of 3.13%.
- In the last 3 months the price of NUS has falen by -32.42%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- Compared to an average industry Dividend Yield of 1.66, NUS pays a better dividend. On top of this NUS pays more dividend than 81.08% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, NUS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.13% |
5.2 History
- The dividend of NUS decreases each year by -30.34%.
- NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 7.39% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP7.39%
EPS Next 2Y1.27%
EPS Next 3YN/A
NUS Fundamentals: All Metrics, Ratios and Statistics
7.17
+0.06 (+0.84%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12 2026-02-12/amc
Earnings (Next)05-06 2026-05-06
Inst Owners77.81%
Inst Owner Change1.2%
Ins Owners2.96%
Ins Owner Change23.34%
Market Cap345.09M
Revenue(TTM)1.49B
Net Income(TTM)160.20M
Analysts45
Price TargetN/A
Short Float %4.26%
Short Ratio3.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.13% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.34%
DP7.39%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27 2026-02-27 (0.06)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.96%
Min EPS beat(2)-4.29%
Max EPS beat(2)12.21%
EPS beat(4)3
Avg EPS beat(4)38.88%
Min EPS beat(4)-4.29%
Max EPS beat(4)73.83%
EPS beat(8)6
Avg EPS beat(8)39.66%
EPS beat(12)9
Avg EPS beat(12)28.85%
EPS beat(16)12
Avg EPS beat(16)23.55%
Revenue beat(2)0
Avg Revenue beat(2)-3.91%
Min Revenue beat(2)-4.19%
Max Revenue beat(2)-3.63%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-4.19%
Max Revenue beat(4)2.51%
Revenue beat(8)4
Avg Revenue beat(8)-1.07%
Revenue beat(12)5
Avg Revenue beat(12)-1.25%
Revenue beat(16)6
Avg Revenue beat(16)-1.69%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-44.44%
EPS NQ rev (3m)-44.44%
EPS NY rev (1m)-29.58%
EPS NY rev (3m)-29.58%
Revenue NQ rev (1m)-7.59%
Revenue NQ rev (3m)-7.59%
Revenue NY rev (1m)-6.67%
Revenue NY rev (3m)-6.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.56 | ||
| Fwd PE | 7.1 | ||
| P/S | 0.23 | ||
| P/FCF | 7.5 | ||
| P/OCF | 4.3 | ||
| P/B | 0.43 | ||
| P/tB | 0.51 | ||
| EV/EBITDA | 2.27 |
EPS(TTM)1.29
EY17.99%
EPS(NY)1.01
Fwd EY14.09%
FCF(TTM)0.96
FCFY13.33%
OCF(TTM)1.67
OCFY23.27%
SpS30.86
BVpS16.73
TBVpS14.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.4% | ||
| ROE | 19.9% | ||
| ROCE | 7.96% | ||
| ROIC | 6.5% | ||
| ROICexc | 8.23% | ||
| ROICexgc | 9.57% | ||
| OM | 6.12% | ||
| PM (TTM) | 10.79% | ||
| GM | 69.45% | ||
| FCFM | 3.1% |
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
ROICexc(3y)5.71%
ROICexc(5y)10.2%
ROICexgc(3y)7.03%
ROICexgc(5y)13.41%
ROCE(3y)5.63%
ROCE(5y)9.71%
ROICexgc growth 3Y-12.47%
ROICexgc growth 5Y-21.24%
ROICexc growth 3Y-9.16%
ROICexc growth 5Y-17.8%
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 4.87 | ||
| Debt/EBITDA | 1.43 | ||
| Cap/Depr | 65.59% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 5.44 | ||
| Cash Conversion | 56.09% | ||
| Profit Quality | 28.72% | ||
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 3.71 |
F-Score7
WACC7.15%
ROIC/WACC0.91
Cap/Depr(3y)69.21%
Cap/Depr(5y)75.81%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.98%
EBIT growth 3Y-17.06%
EBIT growth 5Y-18.81%
EBIT Next Year130.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.42%
FCF growth 3Y-2.08%
FCF growth 5Y-31.95%
OCF growth 1Y-28.15%
OCF growth 3Y-9.44%
OCF growth 5Y-26.69%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 6 / 10 to NUS.
What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?
ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for NUS stock?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 5.56 and the Price/Book (PB) ratio is 0.43.
Can you provide the dividend sustainability for NUS stock?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 7.39%.